Digim Solution LLC
Woburn, MA
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 500 W Cummings Park suite 3650, Woburn, MA 01801, USA
- Website
- digimsolution.com
- Founded
- 2014
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Industrials
- Commercial & Professional Services
- Professional Services
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $612,025 |
| FY2025 | $341,390 |
| FY2024 | $451,390 |
| FY2023 | $269,910 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $612,025 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Lifecanvas Technologies Inc. | Cambridge, MA | 334516 Analytical Laboratory Instrument Manufacturing |
| Scimage Inc. | Los Altos, CA | 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing |
| Thinktrends, LLC | Herndon, VA | 541512 Computer Systems Design Services |
| Digital Medicine Society Inc. | Boston, MA | 813212 Voluntary Health Organizations |
| ICA | Arlington, VA | 541611 Administrative Management and General Management Consulting Services |
About the company
Digim Solution LLC, a minority-owned, woman-owned small business based in Woburn, Massachusetts, delivers 3D imaging, AI-based quantification, and image processing software to the Food and Drug Administration as a prime contractor, with 100% of recent awards concentrated in HHS regulatory and research divisions. The firm is structured as a limited liability partnership and holds Asian-Pacific American ownership designation; it operates exclusively as a prime, holding no subcontract positions across its federal footprint.
Digim's capability portfolio centers on pharmaceutical product characterization and regulatory science. The work spans 3D correlative microscopy imaging, quantitative AI analysis of critical quality attributes (CQAs), drug release simulation software, and image-to-simulation platforms designed to meet FDA 21 CFR Part 11 compliance. Representative prime awards include a $5 million single-award indefinite delivery vehicle (awarded June 2024, running through June 2029) for 3D microscopy, AI-based quantification, and modeling supporting non-clinical evaluation and regulatory activities for complex drug products; a $709,554 definitive contract (awarded September 2022, extended to September 2025) for correlative 3D imaging and AI analysis of polymeric microsphere products; a $500,635 delivery order (awarded September 2026) for 3D correlative imaging and quantitative AI analysis of critical quality attributes for long-acting drugs, inhalation products, and topical products; and a $329,470 purchase order (awarded September 2023, running through September 2028) for image processing, modeling, and simulation software on an HHS blanket purchase agreement vehicle.
Customer concentration is extreme. The FDA accounts for 11 of 12 awards ($8.1 million combined potential value, or 100% of the portfolio's dollar value), with the Centers for Disease Control and Prevention Pittsburgh contributing one $6 thousand award. This deep single-agency posture reflects Digim's regulatory-science specialization and limits customer diversification risk.
The firm places task orders under FDA Indefinite Delivery Contract 75F40124D00022, with two task orders (combined potential value $861 thousand) against that vehicle. The single-award IDV structure limits Digim's full-and-open competitive exposure; most work flows through established FDA relationships and blanket purchase agreements rather than open competitive procurements.
Activity has remained modest and relatively flat — two to three awards per year across 2022–2026 — with only $2.9 million obligated against $8.1 million in combined potential value (35% obligation rate), indicating slower cash conversion than the ceiling values suggest. Three awards (combined potential value $941 thousand) face ultimate completion inside the next twenty-four months, representing moderate recompete exposure. The portfolio skews toward research and development in biotechnology (five awards) and other computer-related services (three awards), reflecting the firm's core positioning in regulatory science tooling.
Quick answers
Is Digim Solution LLC registered in SAM.gov?
Yes. Digim Solution LLC's SAM.gov registration is active through February 6, 2027.
What is Digim Solution LLC's CAGE code?
Digim Solution LLC's CAGE code is 7HVS9, and its Unique Entity ID (UEI) is L33CET9CA421.
How much has Digim Solution LLC received in federal contracts?
Federal contracts obligated $341,390 to Digim Solution LLC in fiscal year 2025 and $1,674,715 in fiscal years 2023 through 2027.
What is Digim Solution LLC's most recent federal award?
Digim Solution LLC's most recent federal contract award is Image processing, modeling and simulation software (75F40126P00121), from Food and Drug Administration, on September 30, 2026.
On GovTribe
See Digim Solution LLC's full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors